BB Biotech AG (BBAGF)
61.55
0.00 (0.00%)
USD |
OTCM |
May 15, 16:00
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | -- |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 91.40% |
| Valuation | |
| PE Ratio | 3.385 |
| PE Ratio (Forward) | |
| PS Ratio | 159.42 |
| Price to Book Value | -- |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | 2.847 |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 0.00 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 58.41% |
Profile
| BB Biotech AG provides investment services for biotechnology sector. It invests in portfolio of companies that are engaged in developing and marketing of innovative biotech drugs. It offers investors a exposure to a focused portfolio of predominantly-US small-to-mid-cap biotech companies developing therapeutic products, towards cell, gene and particularly RNA-based technologies. The company was founded on November 9, 1993 and is headquartered in Schaffhausen, Switzerland. |
| URL | http://www.bbbiotech.com |
| Investor Relations URL | N/A |
| HQ State/Province | Zurich |
| Sector | |
| Industry | |
| Next Earnings Release | Jul. 24, 2026 |
| Last Earnings Release | Apr. 24, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Mar. 24, 2026 |
Profile
| BB Biotech AG provides investment services for biotechnology sector. It invests in portfolio of companies that are engaged in developing and marketing of innovative biotech drugs. It offers investors a exposure to a focused portfolio of predominantly-US small-to-mid-cap biotech companies developing therapeutic products, towards cell, gene and particularly RNA-based technologies. The company was founded on November 9, 1993 and is headquartered in Schaffhausen, Switzerland. |
| URL | http://www.bbbiotech.com |
| Investor Relations URL | N/A |
| HQ State/Province | Zurich |
| Sector | |
| Industry | |
| Next Earnings Release | Jul. 24, 2026 |
| Last Earnings Release | Apr. 24, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Mar. 24, 2026 |
